RIGHTS TO PRODUCT IMPROVEMENTS Sample Clauses

RIGHTS TO PRODUCT IMPROVEMENTS. Subject to the provisions of Section 6.1.9, below, In any Improvements to the Product developed by ORTHOBIO during the term of this Agreement that do not incorporate, modify or improve technology that is proprietary to MENTOR shall be and remain the property solely of ORTHOBIO. MENTOR shall not acquire any interest in ORTHOBIO's proprietary technology or any such Improvements unless such technology or Improvements are made or developed jointly by the parties pursuant to a written development agreement, but all Improvements or modifications to the Products that are intended for use or that can be adapted for use in urological applications are included in this Agreement and subject to the distribution rights granted to MENTOR hereunder.
Sample 1
AutoNDA by SimpleDocs
RIGHTS TO PRODUCT IMPROVEMENTS. Subject to the provisions of Section 7.1.9, below, any Improvements to the Product developed by NAMS during the term of this Agreement that do not incorporate, modify or improve technology that is proprietary to MENTOR shall be and remain the property solely of NAMS. MENTOR shall not acquire any interest in NAMS's Technology or any Improvements unless such technology or Improvements are made or developed jointly by the parties pursuant to a written development agreement, but all Improvements or modifications to the Products that are intended for use or that can be adapted for use in the Field of Use are included in this Agreement and subject to the distribution rights granted to MENTOR hereunder.
Sample 1
RIGHTS TO PRODUCT IMPROVEMENTS. For a period of five (5) years from the termination of the Research Programs, provided that HMRI shall have fully performed its obligations thereunder, HMRI shall be deemed to have acquired an exclusive (non-exclusive in the countries of the world in which this section might otherwise be deemed to violate restrictive trade practices laws), worldwide, royalty-free license to any OSI Improvements to any Compounds or Products. Thereafter, HMRI shall have the sole (i.e., exclusive except as to use only by OSI), worldwide, royalty-free license to any OSI Improvements to any Compounds or Products. OSI shall promptly and fully notify HMRI of any such OSI Improvements. All such OSI Improvements shall be included within the scope of this Agreement. In the event that HMRI (a) elects not to participate in the Contract Period Research Program or (b) discontinues its participation in the Contract Period Research Program prior to the end of the Contract Period by ceasing funding of the Contract Period Research Program in accordance with the provisions of Section 3.2 hereof, or (c) elects not to continue its participation in the Development Phase Program, and OSI accepts the license offered by HMRI upon any of the events listed above, for a period of five (5) years from the date of acceptance of such license by OSI, OSI shall be deemed to have acquired an exclusive (non-exclusive in the countries of the world in which this section might otherwise be deemed to violate restrictive trade practices laws), worldwide, royalty-free license to any HMRI Improvements to any Compounds or Products. Thereafter, -34- 40 OSI shall have the sole (i.e., exclusive except as to use only by HMRI), worldwide, royalty-free license to any HMRI Improvements to any Compounds or Products. HMRI shall promptly and fully notify OSI of any such HMRI Improvements. All such HMRI Improvements shall be included within the scope of this Agreement.
Sample 1
RIGHTS TO PRODUCT IMPROVEMENTS. For a period of five (5) years from the termination of the Research Program, the HOECHST Group shall acquire an
Sample 1
RIGHTS TO PRODUCT IMPROVEMENTS. Notwithstanding Section 5.10, with respect to CSHL Improvements which are developed during the three-year period following the termination of the Research Program, Helicon shall acquire a perpetual, exclusive (nonexclusive in the countries of the world in which this section might otherwise be deemed to violate restrictive trade practices laws), worldwide, royalty-free license in and to such Improvements but only to the extent necessary to guarantee that Helicon can fully enjoy all the rights granted to it pursuant to Article 5 with respect to the use of CSHL Technology and CSHL Improvements developed in the course of the Research Program to develop, make, have made, use and sell Products; provided, however, that with regard to any Improvements made by CSHL resulting from research conducted under the Collaborative Research and License Agreement, such license shall be granted with respect to any such Improvements developed during the five-year period following termination of the Research Program. CSHL retains the right to make and use the CSHL Improvements for research and educational purposes. CSHL shall promptly and fully notify Helicon of any such CSHL Technology developed after the termination of the Research Program.
Sample 1
RIGHTS TO PRODUCT IMPROVEMENTS. Any improvements made by soley by one party will remain that parties property, but in no way does such improvement transfer any rights to use Innova technology, intellectual property, or patents beyond the scope of this agreement. Joint developments with imput from both parties will be available to CamelBak to use, but if patentable, Innova alone shall have the patenting rights.
Sample 1
RIGHTS TO PRODUCT IMPROVEMENTS. Subject to the provisions of Section 5.1.9 below, any Improvements to the Product developed by NASI during the term of this Agreement shall be jointly owned by RADIOMED and NASI, but all Improvements or modifications to Ion Implantation Processing or the Product that are intended for use or that can be adapted for use in the Field of Use developed by RADIOMED are included in this Agreement and are subject to the manufacturing rights granted to NASI hereunder.
Sample 1
AutoNDA by SimpleDocs

Related to RIGHTS TO PRODUCT IMPROVEMENTS

  • Manufacturing Rights Manufacturing Rights will be governed by Attachment 6.

  • Joint Improvements Rights and title to the Technology, whether or not patentable, and any patent applications or patents based thereon, which directly relate to and are not severable from Licensor IP and which are improvements thereto by both LICENSOR AND LICENSEE shall be jointly owned intellectual property by LICENSOR AND LICENSEE.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Rights to Work Product The Employee agrees that all work performed by the Employee pursuant hereto shall be the sole and exclusive property of the Company, in whatever stage of development or completion. With respect to any copyrightable works prepared in whole or in part by the Employee pursuant to this Agreement, including compilations of lists or data, the Employee agrees that all such works will be prepared as “work-for-hire” within the meaning of the Copyright Act of 1976, as amended (the “Act”), of which the Company shall be considered the “author” within the meaning of the Act. In the event (and to the extent) that such works or any part or element thereof is found as a matter of law not to be a “work-for-hire” within the meaning of the Act, the Employee hereby assigns to the Company the sole and exclusive right, title and interest in and to all such works, and all copies of any of them, without further consideration, and agrees, to the extent reasonable under the circumstances, to cooperate with the Company to register, and from time to time to enforce, all patents, copyrights and other rights and protections relating to such works in any and all countries. To that end, the Employee agrees to execute and deliver all documents requested by the Company in connection therewith, and the Employee hereby irrevocably designates and appoints the Company as the Employee’s agent and attorney-in-fact to act for and on behalf of the Employee and in the Employee’s stead to execute, register and file any such applications, and to do all other lawfully permitted acts to further the registration, protection and issuance of patents, copyrights or similar protections with the same legal force and effect as if executed by the Employee. The Company shall reimburse the Employee for all reasonable costs and expenses incurred by the Employee pursuant to this Section 11.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • Development Rights The Employee agrees and declares that all proprietary information including but not limited to trade secrets, know-how, patents and other rights in connection therewith developed by or with the contribution of Employee's efforts during his employment with the Company shall be the sole property of the Company. Upon the Company's request (whenever made), Employee shall execute and assign to the Company all the rights in the proprietary information.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Background IP Each Party will own all right, title and interest in its Background IP.

Time is Money Join Law Insider Premium to draft better contracts faster.